Course Content
The 8th Immunotherapy of Cancer Conference (ITOC8) to be held virtually from October 8 - 9, 2021 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
Learning objectives, training objectives
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and del
Target Audience
Immunology, Oncology, Drug Development, Vaccines, Tumour,
Certifications
A confirmation will be issued after the conference. The conferene will appply for CME accreditation.
Local Organizer
ITOC8 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
Enquiries and Registration:
Please click here https://www.itoc-conference.eu/registration to view registration details
Ms. Catherine Tomek
CategoriesClinical Research, General Medicine, Immunology, Internal Medicine, Medical Education , Oncology, Pharmacology and Toxicology, Tumor Biology
